Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Axitinib treatment turned a man's grey hair back to black.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A certain inhibitor can slow down the decrease in DNA creation in mouse hair follicles, which might help with hair growth.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

PRP may improve fertility treatment success but needs more research for safe use.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Finasteride helps female-pattern hair loss.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Elagolix did not effectively treat polycystic ovary syndrome.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Pantethine may boost the immune system's ability to fight sarcoma.

Most patients experienced significant but reversible hair loss during treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.